Mon. 18 Mar 2024, 4:09pm ET
Benzinga
Earnings, News
Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.34) by 32.35 percent. This is a 30.3 percent increase over losses of $(0.33) per share from the same period last year.